Discussion Section: The Economics of Innovation, Part 1 - Drugs and Patent Protection Published 2018-07-17 Download video MP4 360p Download video MP4 720p Recommendations 58:19 Knowing When to Stop: The Unintended Consequences of Monetary Policy 06:55 Growing skepticism about immigration is a real political economy threat: Sean Speer 56:54 Tearing Down Health Care to Rebuild It for Everyone 05:16 The Expanding Diversity in Economics Summer Institute 35:31 Attacks on Russia's oil infrastructure could mean 'anarchy' for Putin's regime | Owen Matthews 04:50 Introducing the University of Chicago's Market Shaping Accelerator 39:45 Immigration, Crime, and Crime (Mis)Perceptions 06:26 2023 Conference on Discrimination in the 21st Century: Fostering Conversations Across Fields 07:34 Discussion Section: The Economics of Innovation, Part 2 - Recent Work on Risk and Health 45:29 Student Lunch Series: Validating Quality Indicators in Healthcare and Education 04:10 What is market-shaping? Why is it important? 05:06 What are push and pull mechanisms? What are the differences? 02:56 What are some common pitfalls in designing pull mechanisms? 04:32 What are some examples of different kinds of pull mechanisms? 43:14 Prison Overcrowding and Recidivism: Evidence from Colombia 03:39 What makes a problem or market failure suitable for one type of pull mechanism over another? 04:11 How does the Innovation Challenge work? What is the timeline? What can people win? 01:29 Why are we focused on demand-pull incentives? 02:05 What advice would you give to people who are thinking about submitting to the Innovation Challenge? 43:13 Sobrepoblación de Prisiones y Reincidencia: Evidencia de Colombia Similar videos 1:04:36 Patents v Open Innovation: Incentivising ‘Medicines for the Many’ 1:15:33 "Exploring the Current Debate over Patenting Life" - Part 1 32:36 Health Econ 12: Pharmaceutical and Economics of Innovation 1:47:48 Innovation, Justice and Globalization welcome, Panel: The Economics of Innovation and Development 10:00 Discussion Section: Economic Analysis of Healthcare, Part 2 - Challenges with Community Rating 1:38:57 Should we revisit the patent system for pharmaceutical products? 04:51 Economic Analysis of Healthcare, Part 4: What’s a Sensible Approach? 1:22:21 Class 9, Part 1: The Life Science R&D Model and National Institutes of Health (NIH) 1:22:10 U.S. Innovation Competitiveness Summit: Economic Benefits of IP Protection 1:18:02 2018 Undergrad Econ Debate: Should the US Eliminate Patents on Pharmaceuticals? 1:29:06 Eighth Richard Goode Lecture: Innovation, Experimentation, and Economics 1:35:41 Webinar: Innovation and Patents - Issues, Enforcement and Evolvement of the Law in India - 28th Jan 53:23 Immunotherapy & Innovation: A Discussion Of Intellectual Property Issues In The Wake Of COVID-19 1:29:05 "Protecting Intellectual Property Rights In A Global Economy" Part 1 14:38 The Newshour Debate: Cancer Drug Patent V/S Cancer Patient (Part 1 of 3) 1:59:04 Balancing Pharmaceutical Innovation with Public Health in the wake of COVID-19 04:54 How pharmaceutical companies game the patent system | Tahir Amin | Big Think 1:26:41 Public Roundtable Discussion Series on Regulation & Antitrust Law Part 1 of 2 More results